On the day that India launched its Aditya-L1 mission into space, S Somnath, the Chief of the Indian Space Research Organization (ISRO), received a cancer diagnosis. Somnath confirmed the details in an interview with Tarmak Media House, saying that one of the scans showed a growth.

“There were some health issues during the Chandrayaan-3 mission launch. However, it was not clear to me at the time, I did not have a clear understanding about it,” Somnath said.

S Somnath’s family and coworkers were shocked to learn of his cancer diagnosis, as well. The Aditya-L1 mission’s launch and the ISRO Chief’s diagnosis added a personal obstacle to his professional accomplishments.

As Aditya L1, India’s first space-based solar observatory, sailed on its mission to study the Sun on September 2, 2023, S Somnath had a routine scan that revealed an unexpected growth in his stomach.
He went to Chennai for more scans after making the unexpected discovery, which confirmed the presence of a genetic illness. Within a few days, it was confirmed that he had a significant health issue on top of his work obligations.

S Somnath received chemotherapy after surgery.
“It was a shock for the family,” he said, looking back on the event. But these days, I regard cancer and its management as a remedy.” His realistic approach to the illness and its management exhibits a remarkable amount of character strength and an unwavering spirit.

He acknowledged that his fight with cancer was still ongoing, saying, “I harbored uncertainty about a complete cure while undergoing the process.”

But he’s recovered in a way that is truly miraculous. He was only in the hospital for four days before returning to work at Isro, where he worked pain-free from the fifth day onward.
“I’ll be getting frequent examinations and scans. However, I am fully recovered now, and I am back to work,” Somnath remarked.

Read More

Survey Recommends Comprehensive Financial Governance for Mangaluru